Improving patient participation in Parkinson‘s clinical trials: the experience of the Michael J Fox Foundation
暂无分享,去创建一个
Todd Sherer | Sohini Chowdhury | Sohini Chowdhury | T. Sherer | C. Meunier | Claire Meunier | Lily Cappelletti | L. Cappelletti
[1] J. Haas,et al. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors , 2013, Cancer Causes & Control.
[2] P. Kaufmann,et al. The natural history of “contrast stasis” within aneurysm after embolization , 2013 .
[3] P Kaufmann,et al. Recruitment and retention monitoring: facilitating the mission of the National Institute of Neurological Disorders and Stroke (NINDS). , 2012, Journal of vascular and interventional neurology.
[4] S. Page,et al. Recruitment, retention, and blinding in clinical trials. , 2013, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.
[5] G. Pond,et al. A comparison of patient knowledge of clinical trials and trialist priorities. , 2013, Current oncology.
[6] Verena Schadewaldt,et al. Clinical trial recruitment--a complex intervention? , 2013, Journal of clinical nursing.
[7] Sohini Chowdhury,et al. Overcoming obstacles in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[8] L. Tennakoon,et al. Challenges in recruitment of research participants , 2003 .
[9] Raisa B Gul,et al. Clinical trials: the challenge of recruitment and retention of participants. , 2010, Journal of clinical nursing.
[10] A. Singleton,et al. The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.